Kidrolase Market Insights, Forecast to 2025 Published on : 18 June 2019
Report overview Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.
The following manufacturers are covered in this report: •Jazz Pharmaceuticals •Shire •Medac GmbH •Kyowa Hakko Kirin •Qianhong Bio-pharma •Taj Pharmaceuticals •Mingxing Pharma •Exova (SL Pharma) •United Biotech
Kidrolase Market By Region North America
Europe
China Japan
Rest of the world
+91-8087042414 (Asia) | (+1) 646 781 7170 (Int'l) | help@grandresearchstore.com
Kidrolase Market Size
Expected to reach $xx million USD by the end of
2019
Forecast year
2025
Base year
CAGR xx% (2019 - 2025) +91-8087042414 (Asia) | (+1) 646 781 7170 (Int'l) | help@grandresearchstore.com
Kidrolase Market Insights, Forecast to 2025 Application 1
Application 2
By
Application 3
Application Application 4
Application 5
+91-8087042414 (Asia) | (+1) 646 781 7170 (Int'l) | help@grandresearchstore.com
Kidrolase Market Insights, Forecast to 2025
Download Free Sample
Get in touch
Sample includes
Call:
Table Of Contents
+91-8087042414 (Asia)
List of Tables & Figures
(+1) 646 781 7170 (Int'l)
Charts
Research Methodology
E-mail: help@grandresearchstore.com